-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Ovintiv, Raises Price Target to $85

Benzinga·11/13/2026 15:52:22
Listen to the news
Barclays analyst Betty Jiang maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $80 to $85.